BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| ß-glucan {Beta-Glucan} - Candidatus Akkermansia intestinavium |
👶
The Immunomodulatory Effect of ß-Glucan Depends on the Composition of the Gut Microbiota. Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 17 Pages: Pub: 2023 Aug 22 Epub: 2023 Aug 22 Authors Sung M , Yoon Y , Lee J , Html Article Publication |
| ß-glucan {Beta-Glucan} - Candidatus Akkermansia intestinavium |
👶
ß-Glucan-triggered Akkermansia muciniphila expansion facilitates the expulsion of intestinal helminth via TLR2 in mice. Carbohydrate polymers (Carbohydr Polym ) Vol: 275 Issue Pages: 118719 Pub: 2022 Jan 1 Epub: 2021 Oct 2 Authors Jin X , Liu Y , Wang J , Wang X , Tang B , Liu M , Liu X , Publication |
| ß-glucan {Beta-Glucan} - Candidatus Akkermansia intestinavium |
👶
Gut microbiota modulation and inflammation mitigation in a murine model through a hull-less and purple grain barley genotype. Food & function (Food Funct ) Vol: Issue Pages: Pub: 2025 Feb 25 Epub: 2025 Feb 25 Authors Cortijo-Alfonso ME , Laghouaouta H , Pena RN , Martínez M , Yuste S , Rubió-Piqué L , Piñol-Felis C , Publication |
| ß-glucan {Beta-Glucan} - Candidatus Akkermansia intestinavium |
👶
Oat protein isolate-Pleurotus ostreatus ß-glucan conjugate nanoparticles bound to ß-carotene effectively alleviate immunosuppression by regulating gut microbiota. Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 1867-1883 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Zhong L , Hu Q , Zhan Q , Zhao M , Zhao L , Publication |
| ß-glucan {Beta-Glucan} - Candidatus Akkermansia intestinavium |
👶
Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study. Pediatric research (Pediatr Res ) Vol: 95 Issue 6 Pages: 1519-1527 Pub: 2024 May Epub: 2023 Dec 13 Authors Asensio-Grau A , Heredia A , García-Hernández J , Cabrera-Rubio R , Masip E , Ribes-Koninckx C , Collado MC , Andrés A , Calvo-Lerma J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
